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Abstract: Since biological membranes are composed of lipids and proteins we tested the in 
vitro antioxidant properties of several indoleamines from the tryptophan metabolic 
pathway in the pineal gland against oxidative damage to lipids and proteins of 
synaptosomes isolated from the rat brain. Free radicals were generated by incubation with 
0.1 mM FeCl3, and 0.1 mM ascorbic acid. Levels of malondialdehyde (MDA) plus   
4-hydroxyalkenal (4-HDA), and carbonyl content in the proteins were measured as indices 
of oxidative damage to lipids and proteins, respectively. Pinoline was the most powerful 
antioxidant evaluated, with melatonin, N-acetylserotonin, 5-hydroxytryptophan,   
5-methoxytryptamine, 5-methoxytryptophol, and tryptoline also acting as antioxidants. 
Keywords:  melatonin; pinoline; indoleamine; free radical; lipid peroxidation; protein 
oxidation; synaptosome 
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1. Introduction 
Free radicals are atoms or molecules with one or more unpaired electrons in their outer orbital, 
which makes them unstable, highly reactive species. They are capable of attacking any neighboring 
molecules by abstracting electrons, thereby re-establishing electronic stability [1]. When free radicals 
react with phospholipids of biological membranes, they initiate a chain reaction, known as lipid 
peroxidation, which results in loss of membrane-dependent functions and even cellular death [2]. It has 
been proposed that free radicals alter the structure of proteins and thus contribute to cellular aging [3]. 
These modifications include the oxidation of amino acid residue functional groups, cross-linking, and 
oxidation of the protein backbone, resulting in protein fragmentation [4]. 
Melatonin is a methoxyindole derivative produced in the pineal gland from the essential amino acid 
tryptophan in a four-step process, with the enzyme N-acetyltransferase being the regulator of 
melatonin synthesis [5]. Subsequent studies have demonstrated that melatonin is also produced in other 
tissues such as retina, bone marrow, gastrointestinal tract, gonads and immune system [6–8]. Although 
melatonin was initially considered a modulator of circadian rhythms and seasonal reproduction in 
several mammals, extensive research has verified the antioxidant action of melatonin and its beneficial 
potential in preserving the nervous system from oxidative damage [9]. Melatonin efficiently protects 
biomolecules, including lipids, proteins and nucleic acids [10] and preserves membrane fluidity [11]. 
All these positive effects of melatonin may be related to its ability to scavenge reactive oxygen species 
including hydroxyl (•OH), superoxide anion (O2
•−), and peroxyl radicals (ROO•), singlet oxygen (
1O2), 
nitric oxide (•NO), peroxynitrite anion (ONOO
−) and hypochlorous acid (HClO) [12–17], to stimulate 
antioxidant enzymes such as superoxide dismutase, glutathione peroxidase and catalase [18,19], and to 
inhibit some prooxidant enzymes, e.g., nitric oxide and aminolevulinate synthases [18,20]. 
The nervous system has an elevated blood flow and metabolic rate in mammals. Nerve tissue is 
highly sensitive to free radicals for several main reasons: firstly, the nervous system has a poorly 
developed endogenous antioxidant defense system, secondly, in the membranes of the nervous tissues, 
lipids are rich in polyunsaturated fatty acids, which are particularly sensitive as substrates in the lipid 
peroxidation reaction; and thirdly, certain areas of the brain produce hydrogen peroxide and they are 
rich in iron which may contribute to generating •OH via the Fenton reaction [9,21,22]. 
While numerous studies have shown the ability of melatonin to achieve protection against free 
radical damage to the central nervous system, there is little information regarding the antioxidant 
ability of other pineal indoleamines and β-carbolines synthesized in the pineal gland. In the current 
study, we have investigated and compared the protective effects of melatonin and structurally-related 
compounds in preventing oxidative damage to lipids and proteins in membranes isolated from the 
whole brain. The in vitro model for induction of radical species via the Fenton reaction used a 
combination of FeCl3 plus ascorbic acid, which is widely accepted in the field of oxidative stress 
research [23,24]. Lipid peroxidation was assessed by measuring the concentrations of malondialdehyde 
(MDA) and 4-hydroxyalkenals (4-HDA) and protein oxidation was monitored using methods based  
on carbonylation. Int. J. Mol. Sci. 2010, 11                 
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2. Results and Discussion 
2.1. Time Kinetics of Oxidation in the Synaptosomes 
Incubation of synaptosomes in the absence of iron and ascorbic acid did not modify MDA + 4-HDA 
levels and synaptosomal protein carbonylation. However, the addition of 0.1 mM FeCl3 and ascorbic 
acid to the incubation medium resulted in the elevation of these indices in a time-dependent manner. 
Lipid peroxidation increased steadily during the first 30 min of the incubation period (Figure 1A). 
Since no statistically significant difference occurred between the 30 and 60 min measurements, we 
selected a 30 min incubation period for the subsequent studies. Similarly, protein carbonylation 
increased over the first 60 min and then reached a constant value (Figure 1B). Therefore, we conducted 
all additional studies for a time of 60 min. 
Figure 1. Changes in the levels of lipid (A) and protein (B) oxidations as a function of 
time in synaptosomal membranes incubated at 37 °C in the presence (●) or absence (▲) 
of 0.1 mM FeCl3 and 0.1 mM ascorbic acid. Results are given as means ± SE (n = 6).  
* P < 0.05, compared to controls at the same time. 
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2.2. Tryptophan and 5-hydroxytryptophan 
We examined the effects of tryptophan, a physiological constituent of the proteins, on lipid and 
protein oxidation due to iron and ascorbic acid (Figure 2A). Tryptophan, at concentrations of ≥3 mM, 
significantly increased levels of MDA + 4-HDA in the membrane suspension. Exposure of the 
membrane suspension to 1 mM or higher tryptophan significantly reduced protein oxidation   
(Figure 2A). We have recently shown that 0.01–3 mM tryptophan failed to preserve the fluidity of 
hepatic membranes from the rigidity induced by lipid peroxidation [25].  Int. J. Mol. Sci. 2010, 11                 
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Figure 2. The effects of tryptophan (A) or 5-hydroxy-tryptophan (B) concentrations on 
FeCl3 and ascorbic acid-induced lipid (●) and protein (▲) oxidations in synaptosomes 
isolated from rat brains. The incubation time was 30 min for lipid peroxidation and 1 h for 
protein oxidation. Both indoleamines are expressed as the logarithm of its molar 
concentration. Results are given as means ± SE (n = 6) and are expressed as a percentage 
of control membrane preparations. * P < 0.05 vs. membranes treated only with FeCl3 and 
ascorbic acid. 
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Consistent with our results, tryptophan promoted oxidative stress in the cerebral cortex of rats [26]. 
Moreover, in rats fed with tryptophan-supplemented diets, the amino acid appeared to enhance lipid 
peroxidation in plasma as well as several tissues [27,28]. On the other hand, tryptophan showed a weak 
antioxidant behavior which prevented the formation of the 2,2′-azino-bis(3-ethylbenz-thiazoline-6-
sulfonic acid) (ABTS) cation radical by scavenging •OH and ROO• that was five orders of magnitude 
lower than melatonin [29]. The effect of tryptophan on protein oxidation agree with in vivo studies that 
have claimed that tryptophan reduces edema and oxidative stress in cerulein- or ischemia/reperfusion-
induced pancreatitis [30] and accelerated the healing of gastric ulcers induced by administration of 
acetic acid, ethanol, and aspirin [31,32]. 
5-Hydroxytryptophan is biosynthesized from tryptophan by 5-tryptophan hydroxylase in the pineal 
gland. 5-Hydroxytryptophan prevented lipid and protein oxidations in a concentration-dependent 
manner (Figure 2B). These results are consistent with two previous studies showing that   
5-hydroxytryptophan reduced lipid peroxidation and reversed membrane rigidity in hepatic cells and 
microsomal membranes treated with iron [23,25]. It has been proposed that the indole nucleus of 
tryptophan is the moiety of the molecule responsible for the antioxidant function [33]. Although our 
study did not address the chemical mechanism of the antioxidant activity, according to our results it 
seems reasonable to consider that hydroxylation of the amino acid activates its antioxidant behavior, 
which may be related to its ability to transfer electrons to free radicals. Int. J. Mol. Sci. 2010, 11                 
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2.3. Methoxytryptamine, N-acetylserotonin, and Tryptamine 
The ability of 5-methoxytryptamine, N-acetylserotonin and tryptamine to inhibit MDA + 4-HDA 
formation and to augment the carbonyl content in the proteins of synaptosomal membranes treated 
with FeCl3 and ascorbic acid was concentration-dependent (Figure 3). Tan and colleagues reported the 
first observation of the antioxidant effect of 5-methoxytryptamine [12]. They demonstrated that this 
indoleamine efficiently scavenged •OH produced by photolytic rupture of H2O2. Subsequent reports 
also showed that 5-methoxytryptamine reduced lipid peroxidation induced by FeSO4 and carbon 
tetrachloride in biomembranes as well as a variety of homogenates from several tissues [34–36]. An in 
vivo study reported that 5-methoxytryptamine prevented lipid peroxidation and the decrease in 
glutathione concentrations in active muscles of Sprague-Dawley rats after a period of acute exercise [37]. 
N-Acetylserotonin has been implicated in the acceleration of the pro-oxidant activity of   
ascorbate [38] and its antioxidant role has been supported by several in vitro studies which showed that 
N-acetylserotonin decreased the oxidation in low-density lipoproteins caused by copper [39,40], 
protected DNA against harmful exposure to chromium III and hydrogen peroxide [41], and reduced 
lipid peroxidation due to iron, hydrogen peroxide and 2,2′-azobis(2-amidinopropane) [34,42–45]. In 
addition,  N-acetylserotonin prevented the formation of ultraviolet-radiation-induced cataracts in   
rats [46] as well as hepatic lipid peroxidation in rats treated with the toxin α-naphthylisothiocyanate, 
although in this study the indoleamine failed to prevent increases in hepatic enzymes and bilirubin 
levels in serum [47]. 
Figure  3. Percent-inhibition curves of concentrations of 5-methoxytryptamine (A),   
N-acetylserotonin (B), and tryptamine (C) in reducing FeCl3 and ascorbic acid-induced 
lipid (●) and protein (▲) oxidations in synaptosomal membranes. 5-methoxytryptamine, 
N-acetylserotonin and tryptamine are expressed as a logarithm of its molar concentration. 
Results are given as means ± SE (n = 6) and are normalized with respect to control 
membrane preparations that were not exposed to oxidative conditions. * P < 0.05 vs. 
membranes treated only with FeCl3 and ascorbic acid. 
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Figure 3. Cont.  
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Little is known about the antioxidant ability of tryptamine. This molecule reduced the formation of 
thiobarbituric acid reactive substances (TBARS) induced by tert-butyl hydroperoxide, the 
hyperglycemia subsequent to treatment with alloxan [48], and the nitration of the amino acid tyrosine 
caused by ONOO
− [49]. All these results and our data are in agreement with the observation of 
Poeggeler et al. [29] who calculated the reaction rates of tryptamine in scavenging •OH and ROO• as 
0.80 × 10
6 and 0.96 × 10
6 mol·L
−1·s
−1, respectively. 
Under our experimental conditions, we determined the concentrations of a variety of compounds 
that reduced lipid peroxidation and protein carbonylation by 50% (IC50) (Table 1). Among these 
compounds, the lowest IC50 value for blocking lipid peroxidation was calculated for   
5-methoxytryptamine. However, in terms of protein carbonylation, the IC50 values showed that   
N-acetylserotonin was more active than 5-methoxytryptamine and tryptamine. Thus, it seems 
reasonable to deduce that tryptamine is a molecule with relatively poor antioxidant capacity when 
compared to 5-methoxytryptamine or N-acetylserotonin. The substitution of a hydrogen atom for a 
methoxy group in position 5 of the tryptamine activates its antioxidant behavior, as reflected by a 
reduction of the IC50s required to prevent lipid peroxidation (62.1%) and protein carbonylation 
(14.1%). N-Acetylation of tryptamine and the incorporation of a hydroxyl group in C5 of the indole 
ring also enhanced the antioxidant ability of tryptoline in preventing lipid and protein oxidation by 
50.0 and 83.6%, respectively. These results suggest that methoxylation, hydroxylation, and   
N-acetylation of tryptamine reinforced its protective effect against free radical damage, possibly 
through mechanisms mediated by an improvement of the ability to donate electrons as well as 
modifying the solubility of tryptamine in the incubation medium, which would give greater access of 
the indoleamine to the free radicals. Int. J. Mol. Sci. 2010, 11                 
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Table 1. Calculated concentrations (mM) required to inhibit lipid and protein oxidation by 
a 50% (IC50) in preventing lipid and protein oxidation in synaptosomal membranes 
exposed to FeCl3 and ascorbic acid. 
Substance (n = 6)  Lipid peroxidation  Protein oxidation 
Tryptophan -  2.92 
5-Hydroxytryptophan 3.05  1.01 
5-Methoxytryptamine 0.31  3.40 
N-acetylserotonin 0.42  0.65 
Tryptamine 0.84  3.96 
Melatonin 1.75  1.40 
5-Methoxy-3-indoleacetic acid  -  - 
5-Methoxytryptophol 1.75  0.76 
Tryptoline 1.49  0.63 
Pinoline 0.15  0.25 
2.4. Melatonin 
Melatonin’s inhibitory effects of iron- and ascorbic acid-induced lipid and protein oxidations are 
concentration-dependent (Figure 4). Melatonin at 3 mM prevented both oxidative indices almost 
completely; in this case, no significant differences in MDA + 4-HDA concentration and carbonyl 
contents were observed relative to control membranes without FeCl3 and ascorbic acid. 
The efficiency of melatonin as an antioxidant has been demonstrated in numerous studies [9]. In the 
brain, melatonin prevented lipid peroxidation under various experimental conditions. Thus, this 
indoleamine reversed the prooxidant effects caused by the excitatory amino acid glutamate [50], 
kainic, quinolenic, and okadaic acids [51–53], Alzheimer amyloid peptide [54], 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine [55], homocysteine [56], and bacterial lipopolysaccharide [57]. Melatonin 
also reduced the severity of ischemia-reperfusion injury in brain [58]. Tan and colleagues [12] reported 
that melatonin is a very efficient •OH scavenger, while, in a exhaustive study extended to a wide 
number of antioxidants, Poeggeler et al. [29] claimed that melatonin had an elevated reaction rate with 
•OH and ROO•. Melatonin’s ability to reduce lipid peroxidation is assumed to be related, at least 
partially, to its direct scavenging activity. However, several other mechanisms may be involved in its 
protective effects against these neurotoxins, e.g., by stabilizing cell membranes, allowing them to resist 
effectively free radical toxicity [11], and by stimulating antioxidative enzymes [59].  
Previous in vitro evidence indicates that melatonin protects synaptosomal membranes against lipid 
peroxidation mediated by aluminum and sodium nitroprussiate [24,60,61]. The reduction of 
carbonylation of proteins by melatonin was described for the first time by Kim et al. [62], who proved 
that melatonin reduced the formation of carbonyl groups in a solution of bovine serum albumin treated 
with ascorbate-Fe
3+-EDTA. Daily administration of melatonin in senescence-accelerated mice reduces 
protein carbonylation in the cerebral cortex [63]. These findings are consistent with the results of the 
current study wherein melatonin decreased the accumulation of MDA + 4-HDA levels and protein 
carbonylation in synaptosomes incubated with 0.1 mM FeCl3 and 0.1 mM ascorbic acid.  Int. J. Mol. Sci. 2010, 11                 
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Figure 4. The ability of melatonin to decrease synaptosomal lipid and protein oxidations. 
(●) MDA + 4-HDA concentrations; (▲) carbonyl contents. Melatonin is expressed as the 
logarithm of its molar concentration. Values are means ± SE (n = 6) and are expressed 
relative to comparable control membrane preparations. * P < 0.05 vs. membranes treated 
exclusively with FeCl3 and ascorbic acid. 
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2.5. 5-Methoxytryptophol and 5-methoxy-3-indoleacetic Acid  
Biosynthesis of 5-methoxytryptophol and 5-methoxy-3-indoleacetic acid occurs from serotonin and 
is catalyzed by monoamine oxidase and hydroxyindole-O-methyltransferase [64].   
5-Methoxytryptophol inhibited FeCl3 and ascorbic acid-induced lipid and protein oxidation in a dose-
dependent manner (Figure 5A). The minimal effective concentration of 5-methoxytryptophol that 
significantly reduced oxidative damage was 0.1 mM (P  ≤ 0.05). All concentrations of   
5-methoxytryptophol greater than 0.5 mM caused progressively greater reductions in MDA + 4-HDA 
levels and protein carbonylation in synaptosomal membranes. However, 5-methoxy-3-indoleacetic 
acid failed to protect the membranes in terms of biochemical markers of oxidative stress. Only high 
levels (5 mM) of 5-methoxy-3-indoleacetic acid reduced the synaptosomal carbonylation by 46.1% 
(Figure 5B). 
Under our experimental conditions, 5-methoxytryptophol showed an antioxidant action. Although 
limited knowledge exists on the antioxidant capacity of this indoleamine, our data is in agreement with 
previous reports that demonstrate that 5-methoxytryptophol reduced the formation of the ABTS cation 
radical acting as a potent electron donor [29], decreased iron-induced hepatic microsomal membrane 
rigidity [65], and prevented lipid peroxidation due to hydrogen peroxide in rat brain homogenates [66]. 
Earlier studies with 5-methoxy-3-indoleacetic acid claimed that this molecule was unable to prevent 
the oxidation of low density lipoprotein [36]. However, the 5-methoxy-3-indoleacetic acid reaction 
rate with •OH and ROO•, exclusively when the incubation medium had a very low pH [29]. The 
difference in pH in the incubation medium may explain the lack of antioxidant effect of 5-methoxy-3-
indoleacetic acid in our study. Int. J. Mol. Sci. 2010, 11                 
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Figure 5. Inhibition of lipid (●) and protein (▲) oxidation by 5-methoxytryptophol (A) or 
5-methoxy-3-indoleacetic acid (B) induced by FeCl3 and ascorbic acid. The concentrations 
of these indoleamines are expressed as the decimal logarithm of its molar concentration. 
Percentage inhibitions are shown as means ± SE (n = 6) and are expressed relative to 
control membrane preparations. * P < 0.05 vs membranes treated only with FeCl3 and 
ascorbic acid. 
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2.6. β-Carbolines 
β-carboline formation has been proposed via the Pictet-Spengler reaction by condensation of 
indoleamines with aldehydes [64,67]. We observed that progressively increasing concentrations of 
tryptoline or pinoline prevented MDA + 4-HDA formation and protein carbonylation in a 
concentration-dependent manner (Figure 6). Pinoline proved to be more potent than tryptoline in 
reducing lipid and protein oxidation. These data agree with a previous study showing that pinoline was 
more active in reducing lipid peroxidation in brain homogenates exposed to hydrogen peroxide [68]. 
Tryptoline differs from pinoline in the absence of the methoxy group. It has been proposed that 
methoxylated tryptophan derivatives are more effective antioxidants than hydroxylated   
compounds [12,29]. The data reported here for β-carbolines is consistent with this observation. Several 
reports have claimed that pinoline reduced lipid peroxidation induced by hydrogen peroxide, iron, 
sodium nitroprussiate, copper (I) iodide, aluminum, and glutamate [24,44,60,68–71]. Herein, we show 
for the first time that tryptoline also reduces oxidative stress in synaptosomal membranes. As for 
pinoline, our data are in agreement with two previous studies stating that pinoline limits oxidative 
damage to proteins in synaptosomes [24,60]. Int. J. Mol. Sci. 2010, 11                 
 
 
321
Figure 6. Response of tryptoline (A) or pinoline (B) in preserving synaptosomes from lipid 
(●) and protein (▲) oxidation after oxidative stress. The concentrations of these   
β-carbolines are expressed as the decimal logarithm of its molar concentration. Values are 
means  ± SE (n = 6) and are expressed relative to control synaptosome preparations.   
* P < 0.05 vs membranes treated exclusively with FeCl3 and ascorbic acid. 
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3. Experimental Section 
3.1. Chemicals 
All chemical reagents were of the purest available quality obtainable from commercial sources. 
FeCl3, ascorbic acid, melatonin, tryptophan, 5-hydroxytryptophan, 5-metoxytryptamine, N-acetyl-
serotonin, tryptamine, melatonin, 5-methoxy-3-indoleacetic acid, 5-methoxytryptophol, tryptoline, and 
pinoline were purchased from Sigma-Aldrich (Madrid, Spain). The Bioxytech LPO-586 kit for lipid 
peroxidation was obtained from Cayman Chemical (Ann Arbor, MI, USA). Melatonin was diluted in 
absolute ethanol and Tris-HCl 50 mM, with ethanol constituting 2% (v/v) of the final solution. 
Tryptamine, 5-methoxytryptamine, 5-methoxytryptophol, 5-methoxy-3-indoleacetic acid, and pinoline 
were diluted in methanol and incubation buffer; the concentration of methanol was 2% (v/v) in the 
final solution. The rest of the reagents were dissolved in incubation buffer. All solutions were freshly 
prepared just prior to use. 
3.2. Animals and Isolation of Synaptosomes 
Fifty Sprague-Dawley male rats, weighing 200–250 g were purchased from Harlan-Ibérica 
(Barcelona, Spain). Before being sacrificed, they were acclimated for two weeks, three animals in each 
Plexiglas cage. The brains were quickly removed, washed in cold saline solution (0.9% NaCl), and 
homogenized 1/10 (w/v) in 0.32 M sucrose using a motor-driven Teflon homogenizer. Membranes 
were isolated following the protocol previously described by Millán-Plano and co-workers [24]. 
Briefly, tissue homogenates were centrifuged at 1,000 × g at 4 °C for 10 min to remove the nuclei and Int. J. Mol. Sci. 2010, 11                 
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cellular debris. Then, supernatants were centrifuged at 30,000 × g for 20 min at 4 °C and the resulting 
pellets were resuspended in H2O (1/10, v/v), homogenized, and centrifuged at 10,000 × g for 20 min at 
4 °C. Following this centrifugation, supernatant and buffy coat was removed, homogenized, and then 
recentrifuged at 48,000 × g at 4 °C for 20 min The pellet was washed twice and the final pellet was 
resuspended 1/2 (v/v) in Tris-HCl buffer (pH = 7.4), and frozen at −80 °C until assay. 
3.3. Experimental Design 
The induction of oxidative stress to the synaptosomal membranes was performed by using a •OH 
generator system. This system was based on the models proposed by Wong et al. [72] and Sahu and 
Washington [73] using FeCl3 and ascorbic acid as prooxidative reagents. Aliquots of synaptosomal 
membranes, 0.5 mg/mL, were suspended in Tris-HCl 50 mM buffer and incubated in a water bath with 
shaking at 37 °C with or without 0.1 mM FeCl3, 0.1 mM ascorbic acid and in the absence or presence 
of the indoleamines (0.001–5 mM). The duration of the incubation was determined by time kinetics, 
measuring the formation of MDA + 4-HDA and carbonyl groups over 120 min after initiating 
incubation. The oxidation of the membranes was quenched by adding 2 mM EDTA and by placing the 
membrane solution into ice-cold water for 10 min. Control synaptosomes and those with induced 
oxidation were exposed to the same conditions (incubation and addition of ethanol or methanol) as the 
samples treated with the indoleamines. 
3.4. Analytical Procedures 
MDA + 4-HDA levels were used as an index of peroxidation of the synaptosomal lipids [74]. The 
levels of the lipid peroxidation products were measured using the Bioxytech LPO-586 kit. In this 
assay, MDA and 4-HDA react with N-methyl-2-phenylindole to yield a stable chromophore with a 
peak of maximum absorbance at 586 nm. Results are expressed as nmol MDA + 4-HDA/mg of 
synaptosomal protein. The protein concentrations were determined employing the method of   
Lowry [75], using bovine serum albumin as the standard. 
Carbonyl groups in the synaptosomal proteins were measured using the reaction with   
2,4-dinitrophenylhydrazine (DNPH) described by Levine et al. [76], with slight modifications. 
Aliquots (100 μL) of 50 mM Tris-HCl buffer and 200 μL of 10 mM DNPH solution were added to  
1 mL of synaptosomal membranes, and the mixture was incubated al 37 °C for 1 h. Aliquots (325 μL) 
of 50% ice-cold trichloroacetic acid was added to the mixture and the samples were placed on ice for 
10 min. The pellets obtained after centrifugation at 3,000 × g for 10 min were washed three times with 
ethanol/ethyl acetate (1:1, v/v). The final pellets after the third washing were dissolved in 6 M 
guanidine and incubated at 37 °C for 15 min. After centrifugation at 12,000 × g for 10 min, the 
absorbance of the supernatants was measured spectrophotometrically at 375 nm. Protein carbonyl 
groups were estimated by using the molar absorption coefficient of 22,000 M
−1·cm
−1 for DNPH 
derivatives, and its concentration was expressed as nmol carbonyl groups/mg protein. Guanidine 
solution was used as a blank. Int. J. Mol. Sci. 2010, 11                 
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3.5. Statistical Analysis 
All results are expressed as means ± standard error of at least five independent experiments. 
Student’s  t-tests were used for comparison of the means. Differences were accepted as being 
statistically significant when P < 0.05. 
4. Conclusions 
The findings presented in this paper demonstrate that melatonin and other structurally-related 
compounds afford protection against FeCl3 and ascorbic acid-induced lipid and protein oxidation in 
synaptosomes isolated from rat brain and reinforce the idea that several secretory products of the 
pineal gland may play a role in protecting biological membranes from oxidative damage. Table 1 
summarizes the concentrations of these molecules required to reduce lipid and protein oxidations by 
50% (IC50). Although these results suggest that pinoline is the most powerful antioxidant evaluated 
under our in vitro experimental conditions, since there is no data regarding the in vivo effects of  
β-carbolines, further studies should be conducted to define the antioxidant properties of these 
molecules. Regarding the indoleamines, while ample evidence demonstrates that melatonin achieves 
neuroprotection in vivo against free radical damage in a range of toxicological models [9,10], further 
studies are needed to verify the antioxidant behavior of other indoleamines. When melatonin was 
compared in vivo to other indoleamines, melatonin appeared to be a more active antioxidant and free 
radical scavenger [47]. Our results are consistent with the idea that several indoleamines and   
β-carbolines contribute to the antioxidant role of the pineal gland. 
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